Results 1 to 10 of about 20,765 (154)

A systematic review and pharmacovigilance analysis of the risk of agranulocytosis associated with metamizole use [PDF]

open access: yesScientific Reports
Metamizole is an analgesic widely used after its introduction but later withdrawn in several countries due to the risk of agranulocytosis. Despite this, it remains frequently used worldwide.
Alessia Zinzi   +7 more
doaj   +2 more sources

Predicting clozapine-induced adverse drug reaction biomarkers using machine learning [PDF]

open access: yesScientific Reports
Clozapine is an atypical antipsychotic used for patients with treatment-resistant schizophrenia. This drug has serious adverse drug reactions (ADRs), including the risk of severe neutropenia (agranulocytosis).
John-Paul Cooper   +3 more
doaj   +2 more sources

Ceftazidime‐Induced Agranulocytosis: A Case Report [PDF]

open access: yesClinical Case Reports
The most common adverse events associated with ceftazidime include hypersensitivity reactions, gastrointestinal disturbances, and transient abnormal liver function tests, whereas neutropenia is a rare complication.
Bingbin Dong, Xin Wu, Changbao Huang
doaj   +2 more sources

A case of idiosyncratic drug‐induced agranulocytosis because of sulbactam/ampicillin [PDF]

open access: yesJournal of General and Family Medicine
Idiosyncratic drug‐induced agranulocytosis is a rare but life‐threatening condition that requires immediate medical intervention. Although sulbactam/ampicillin (SBT/ABPC) is a widely used antibiotic, no prior case reports of its associated ...
Kazuya Toda   +4 more
doaj   +2 more sources

Pharmacogenetics of metamizole-induced agranulocytosis: a systematic review and drug regulation implications [PDF]

open access: yesFrontiers in Pharmacology
IntroductionMetamizole (dipyrone) is a widely used analgesic and antipyretic, but its use has been restricted in some countries due to the risk of metamizole-induced agranulocytosis (MIA).
Giovana Fernanda Santos Fidelis   +10 more
doaj   +2 more sources

HLA-DQB1 6672G>C (rs113332494) is associated with clozapine-induced neutropenia and agranulocytosis in individuals of European ancestry

open access: yesTranslational Psychiatry, 2021
The atypical antipsychotic clozapine is the only effective medication for treatment-resistant schizophrenia. However, it can also induce serious adverse drug reactions, including agranulocytosis and neutropenia.
Bettina Konte   +26 more
doaj   +1 more source

Distinctive pattern of neutrophil count change in clozapine-associated, life-threatening agranulocytosis

open access: yesnpj Schizophrenia, 2022
The wider use of clozapine is limited by the risk of agranulocytosis and the associated requirement for monitoring of neutrophil counts. We searched local electronic patient records for cases of agranulocytosis occurring during clozapine treatment during
David Taylor   +4 more
doaj   +1 more source

Agranulocytosis induced by metamizole and its management with granulocyte growth factor [PDF]

open access: yesVojnosanitetski Pregled, 2005
Drug-induced agranulocytosis was defined as a severe selective neutropenia caused by an unexpected drug reaction. Metamizole was the most common nonopioid analgesic drug associated with agranulocytosis.
Čeleketić Dušica   +2 more
doaj   +1 more source

Can propylthiouracil induce autoimmune-related immunotoxicity? [PDF]

open access: yesVojnosanitetski Pregled, 2022
Introduction. The use of propylthiouracil can be associated with mild adverse reactions, but severe complications such as agranulocytosis and vasculitis can also be seen.
Bajkin Ivana   +4 more
doaj   +1 more source

Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study

open access: yesSwiss Medical Weekly, 2023
BACKGROUND: Carriers of germline pathogenic variants of the BRCA1 gene (gBRCA1) tend to have a higher incidence of haematological toxicity upon exposure to chemotherapy.
Noémie Lang   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy